This drug maker's kidney disease treatment scores $50M payday
February 11, 2020 at 18:05 PM EST
If the FDA approves the drug, it will be FibroGen's first U.S. approval.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.